BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tanaka M, Heckler M, Mihaljevic AL, Probst P, Klaiber U, Heger U, Schimmack S, Büchler MW, Hackert T. Systematic Review and Metaanalysis of Lymph Node Metastases of Resected Pancreatic Neuroendocrine Tumors. Ann Surg Oncol 2021;28:1614-24. [PMID: 32720049 DOI: 10.1245/s10434-020-08850-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Heidsma CM, Tsilimigras DI, Rocha F, Abbott DE, Fields R, Poultsides GA, Cho CS, Lopez-Aguiar AG, Kanji Z, Fisher AV, Krasnick BA, Idrees K, Makris E, Beems M, van Eijck CHJ, Nieveen van Dijkum EJM, Maithel SK, Pawlik TM. Identifying Risk Factors and Patterns for Early Recurrence of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study. Cancers (Basel) 2021;13:2242. [PMID: 34067017 DOI: 10.3390/cancers13092242] [Reference Citation Analysis]
2 Andreasi V, Ricci C, Partelli S, Guarneri G, Ingaldi C, Muffatti F, Crippa S, Casadei R, Falconi M. Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis. J Endocrinol Invest 2021. [PMID: 34773595 DOI: 10.1007/s40618-021-01705-2] [Reference Citation Analysis]
3 Tanaka M, Hackert T. ASO Author Reflections: Lymph Node Metastasis in Pancreatic Neuroendocrine Tumor. Ann Surg Oncol 2020;27:863-4. [PMID: 32720037 DOI: 10.1245/s10434-020-08941-5] [Reference Citation Analysis]
4 Nießen A, Schimmack S, Billmann F, Hackert T. [Surgery of pancreatic neuroendocrine neoplasms: state of the art]. Chirurg 2022. [PMID: 35499762 DOI: 10.1007/s00104-022-01641-8] [Reference Citation Analysis]
5 Huang J, Xie X, Wu H, Zhang X, Zheng Y, Xie X, Wang Y, Xu M. Development and validation of a combined nomogram model based on deep learning contrast-enhanced ultrasound and clinical factors to predict preoperative aggressiveness in pancreatic neuroendocrine neoplasms. Eur Radiol 2022. [PMID: 35389050 DOI: 10.1007/s00330-022-08703-9] [Reference Citation Analysis]
6 An C, Li D, Li S, Li W, Tong T, Liu L, Jiang D, Jiang L, Ruan G, Hai N, Fu Y, Wang K, Zhuo S, Tian J. Deep learning radiomics of dual-energy computed tomography for predicting lymph node metastases of pancreatic ductal adenocarcinoma. Eur J Nucl Med Mol Imaging 2021. [PMID: 34651229 DOI: 10.1007/s00259-021-05573-z] [Reference Citation Analysis]
7 Gao B, Zhou D, Qian X, Jiang Y, Liu Z, Zhang W, Wang W. Number of Positive Lymph Nodes Is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms. Front Endocrinol (Lausanne) 2021;12:613755. [PMID: 33746899 DOI: 10.3389/fendo.2021.613755] [Reference Citation Analysis]
8 Frey S, Mirallié E, Le Bras M, Regenet N. What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative Review. Cancers (Basel) 2021;13:5954. [PMID: 34885063 DOI: 10.3390/cancers13235954] [Reference Citation Analysis]
9 de Ponthaud C, Menegaux F, Gaujoux S. Updated Principles of Surgical Management of Pancreatic Neuroendocrine Tumours (pNETs): What Every Surgeon Needs to Know. Cancers (Basel) 2021;13:5969. [PMID: 34885079 DOI: 10.3390/cancers13235969] [Reference Citation Analysis]